En este caso, existe otro factor preocupante. Merck y Schering-Plouh, que operan de consuno, revelaron este martes que habían modificado los “fines primarios”, o sea los resultados eventualmente ...

In a report released on October 4, Carter Gould from Barclays maintained a Buy rating on Merck & Company (MRK – Research Report), with a price target of $140.00. The company’s shares closed ...

(RTTNews) - Drug makers Exelixis, Inc. (EXEL) and Merck & Co Inc.(MRK) announced Monday that they have entered into a clinical development collaboration to evaluate the combination of Exelixis ...

German science and technology group Merck is open to more acquisitions for its Life Science business after announcing in May ...

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Merck KGaA cut its mid-term sales growth target for its health-care division after a number of high-profile drug trial ...

The German company said booming artificial-intelligence demand would help its electronics sales grow faster than previously ...

Merck & Co., Inc. es una compañía global de cuidado de la salud. La compañía ofrece soluciones de salud a través de sus medicamentos recetados, vacunas, terapias biológicas y productos de ...

British drugmaker GlaxoSmithKline sued Moderna in U.S. federal court in Delaware on Tuesday, accusing its American rival of ...

It spiked after the company released late-stage trial data showing one of its drugs, Ivonescimab, performed better than Merck's blockbuster Keytruda medication in some lung cancer patients.

We recently compiled a list of the 7 Blue Chip Stocks with Low PE Ratios. In this article, we are going to take a look at ...

Merck & Co. has picked up options on two Evaxion Biotech vaccine candidates, paying $3.2 million and dangling more than $1 billion in milestones for the chance to pick up preclinical prospects ...